Interleukins and Ischemic Stroke

293Citations
Citations of this article
315Readers
Mendeley users who have this article in their library.

Abstract

Ischemic stroke after cerebral artery occlusion is one of the major causes of chronic disability worldwide. Interleukins (ILs) play a bidirectional role in ischemic stroke through information transmission, activation and regulation of immune cells, mediating the activation, multiplication and differentiation of T and B cells and in the inflammatory reaction. Crosstalk between different ILs in different immune cells also impact the outcome of ischemic stroke. This overview is aimed to roughly discuss the multiple roles of ILs after ischemic stroke. The roles of IL-1, IL-2, IL-4, IL-5, IL-6, IL-8, IL-9, IL-10, IL-12, IL-13, IL-15, IL-16, IL-17, IL-18, IL-19, IL-21, IL-22, IL-23, IL-32, IL-33, IL-34, IL-37, and IL-38 in ischemic stroke were discussed in this review.

Cite

CITATION STYLE

APA

Zhu, H., Hu, S., Li, Y., Sun, Y., Xiong, X., Hu, X., … Qiu, S. (2022, January 31). Interleukins and Ischemic Stroke. Frontiers in Immunology. Frontiers Media S.A. https://doi.org/10.3389/fimmu.2022.828447

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free